drugset / Trial / NCT00002531

Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia

NCT00002531

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Randomized phase II trial to study the effectiveness of various combination chemotherapy regimens in treating patients with acute lymphocytic leukemia.

Timeline

Start
1993-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified Intravenous
Subject Cytarabine Small molecule Intravenous
Subject Daunorubicin Small molecule Intravenous
Subject Dexamethasone Small molecule Oral
Subject Doxorubicin Other / unclassified Intravenous
Subject Etoposide Small molecule
Subject Ifosfamide Small molecule Intravenous
Subject MERCAPTOPURINE ANHYDROUS Small molecule Oral
Subject Methotrexate Small molecule Intravenous
Subject Mitoxantrone Small molecule Intravenous
Subject Prednisolone Other / unclassified Oral
Subject Teniposide Small molecule Intravenous
Subject Thioguanine Small molecule Oral
Subject Vincristine Small molecule Intravenous
Subject Vindesine Small molecule
Subject asparaginase Protein / enzyme biologic Intravenous
Background Leucovorin Small molecule

Indications